Industry Verticals »

All Categories

Insights »

About TMR »

Heparin Market

Heparin Market (Product - Unfractionated Heparin (UFH), Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMWH); Source - Bovine and Porcine; Formulation - Oral and Parenteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019- 2027

Global Heparin Market to Ride on the Back of High Prevalence of Cardiovascular Diseases

The rising number of surgeries and injuries is projected to be a major cause in the expansion of the global heparin market in the years to come. In addition to that, the rising prevalence of cardiovascular diseases and venous thromboembolism is projected to drive the demand for heparin in near future. Few biopharmaceutical firms are putting money into new drug development and manufacturing. Organizations such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are working to raise awareness via efforts aimed at reducing thrombosis-related complications in the early stages.

The global heparin market is projected to benefit from augmented demand for anticoagulants. In addition to that, high healthcare costs and low patient recognition are two major reasons expected to propel the industry forward in the coming years.

Increasing Use in Treating a Wide Variety of Illnesses to Boost Demand in the Market

Heparin is a drug that is utilized to cure or avoid a wide variety of lung, heart, and blood vessel, heart diseases. It's also utilized in the prevention of disorders pertaining to blood clotting, prophylaxis blood screening, and blood transfusions. Disseminated intravascular coagulation is a severe blood disease that can be diagnosed and treated with heparin. To avoid birth loss and other complications, heparin is often used alone or in conjunction with aspirin. Such extensive use of the drug is likely to support growth of the global heparin market

In addition to that, a spike in the number of surgical procedures and the high prevalence of illnesses such as coronary heart disease and deep vein thrombosis are likely to accentuate demand for heparin, resulting in market development. As per a 2018 report by American Heart Association, coronary heart disorder causes fatalities over 366,800 people in the US each year, accounting for one in every seven deaths. According to the same article, the total incidence of myocardial infarction (MI) in the US is about 7.9 million, or 3% of adult Americans.

The restraints of the global heparin market comprise the side effects associated with the consumption of heparin. Bleeding is heparin's most known side effect. the mouth and gums, uterus, ovaries, intestines, o pen wounds or surgical sites are all locations where heparin can cause accidental bleeding.

  • According to Transparency Market Research’s latest report on the global heparin market for the historical period 2017–2018 and forecast period 2019–2027, high incidence and mortality associated with coagulation disorders, commercialization of safe and cost-effective heparin products are projected to drive the global heparin market during the forecast period
  • According to the report, the global heparin market was valued at US$ 10.8 Bn in 2018 and is anticipated to expand at a CAGR of 6.8% from 2019 to 2027

High incidence and mortality associated with coagulation disorders and commercialization of safe and cost-effective heparin products: Key Drivers

  • Coagulation disorders such as venous thromboembolism (VTE) cause nearly half a Mn deaths in Europe each year. Astonishingly, the number of deaths due to VTE in Europe is more than the deaths collectively caused by AIDS, breast and prostate cancers, and highway accidents. According to the Centers for Disease Control and Prevention (CDC), the annual incidence of VTE (DVT & PE) in general population is estimated to be around 0.1%. Moreover, it states that approximately 900,000 people are affected by DVT/PE in the U.S. every year and one third of the DVT/PE patients have a recurrence within a decade.
  • A report published by Bayer HealthCare in 2013 stated that the incidence of VTE is expected to increase by 8% by 2018. These statistics clearly indicate the rising demand for safe, reliable, and affordable anticoagulants which would act as a growth driver for the heparin market. The prevailing limitation in reversing the activity of naturally-derived low molecular weight heparin (LMWH) in case of overdose could lead to excessive bleeding and harm to patients with poor kidney function. In 2014, researchers at the Rensselaer Polytechnic Institute and the University of North Carolina (UNC) developed a synthetic form of LMWH that is safe and can be reversed in activity using an antidote called protamine. According to the research, this synthetic heparin is safer and cheaper than the currently available heparin which is derived from animals. Regulatory approval would generate even higher demand for this synthetic version while affecting the existing demand for naturally derived heparin.

Request a sample to get extensive insights into the Heparin Market

Rising Geriatric Population is Affected More by Thrombosis Boost Market Growth

  • Venous thromboembolism (VTE) is highly common in the geriatric population; however, it can occur at any age. The incidence rate of various disease such as heart failure, which can lead to thrombosis and is likely to occur more in old age than compare to young age
  • Congestive heart failure is much more frequent in elderly people, with 85% of patients with heart failure being older than 65 years. The prevalence of atrial fibrillation increases three times in people aged 80 years and above, as compared to those aged less than 65 years. Such incidences increase the risk of pulmonary embolism, more in the geriatric population, as the geriatric population with heart failure have limited heart and lung function, and the symptoms caused by even a small pulmonary embolism are more noticeable.
  • Hence, rising geriatric population is expected to drive the market for heparin drugs during the forecast period

Presence of alternative anticoagulants impeding the sale of biological heparin products to Hamper Market

  • Presence of alternative anticoagulants such as warfarin, oral anticoagulants, and coumarins is restraining the market for heparin used in the treatment of embolism.
  • Warfarin has traditionally been the key preferred drug for anticoagulant therapy globally. Moreover, the advent of new anticoagulants such as rivaroxaban, dabigatran, and apixaban is cannibalizing the market share of heparin globally.
  • Heparin is derived from animal sources; hence, the risk of infection and contamination always exists. Although these substitutes also possess certain limitations in terms of side effects and drug interactions, a physician can prefer these drugs over heparin depending on the condition of the patient and the type of disorder.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Global Heparin Market: Competitive Landscape

  • This report profiles major players in the global heparin market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global heparin market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global heparin market are
    • Dr. Reddy’s Laboratories Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Fresenius SE & Co. KGaA
    • Sanofi
    • Pfizer, Inc.
    • LEO Pharma A/S
    • Aspen
    • Baxter International Inc.,
    • B. Braun Melsungen AG
    • Syntex S.A. among others

Stuck in a neck-to-neck competition with other brands? Request a custom report on Heparin Market

Global Heparin Market: Key Developments

Key players in the global heparin market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global heparin market. A few expansion strategies adopted by players operating in the global heparin market are:

  • In September 2019, Meitheal Pharmaceuticals announced the launch of heparin sodium injection, USP in the United States (US).
  • In April 2019, B. Braun Medical Inc. launched Heparin Sodium Injection, USP - the first Heparin 5,000 USP Unit / 0.5 mL prefilled syringe with attached safety needle for subcutaneous and intravenous use in the United States.
  • In December 2017, Mylan received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Heparin Sodium Injection USP, 1,000 USP/mL, 5,000 USP/mL, 10,000 USP/mL, and 20,000 USP/mL, all of which are packaged in multi-dose vials.

The report on the global heparin market discussed individual strategies, followed by company profiles of manufacturers of heparin. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global heparin market.

Global Heparin Market - Segmentation

Product
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-low Molecular Weight Heparin (ULMWH)
  • Unfractionated Heparin (UFH)

Source
  • Bovine
  • Porcine

Formulation
  • Oral
  • Parenteral

Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of heparin market?

Heparin market to gain a valuation of US$ 19.4 Bn by 2027

What is the anticipated CAGR of the heparin market in the forecast period?

Heparin market is estimated to reach a CAGR of 6.8% from 2019 to 2027

What are the key driving factors for the growth of the heparin market?

Heparin market is driven by rising geriatric population and rising prevalence of cardiovascular diseases and venous thromboembolism

Which region is expected to project the highest market share in the global heparin market?

North America accounted for a major share of the global heparin market

Who are the key players in the global heparin market?

Key players in the heparin market include Syntex S.A., B. Braun Melsungen AG, Baxter International Inc., Aspen, LEO Pharma A/S, Pfizer, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Heparin Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Heparin Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Market Strategies adopted by Top Players

        5.2. Snapshot – Brand Analysis

        5.3. Porter’s Five Forces Analysis

    6. Global Heparin Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Heparin Market Value Forecast, by Product, 2017–2027

            6.2.1. Low Molecular Weight Heparin (LMWH)

            6.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

            6.2.3. Unfractionated Heparin (UFH)

        6.3. Global Heparin Market Attractiveness, by Product

    7. Global Heparin Market Analysis and Forecast, by Source

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Heparin Market Value Forecast, by Source, 2017–2027

            7.2.1. Bovine

            7.2.2. Porcine

        7.3. Global Heparin Market Attractiveness, by Source

    8. Global Heparin Market Analysis and Forecast, by Formulation

        8.1. Introduction & Definition

            8.1.1. Key Findings / Developments

        8.2. Global Heparin Market Value Forecast, by Formulation, 2017–2027

            8.2.1. Oral

            8.2.2. Parenteral

        8.3. Global Heparin Market Attractiveness, by Formulation

    9. Global Heparin Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Global Heparin Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. North America Heparin Market Attractiveness, by Region

    10. North America Heparin Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. North America Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

            10.2.1. Low Molecular Weight Heparin (LMWH)

            10.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

            10.2.3. Unfractionated Heparin (UFH)

        10.3. North America Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

            10.3.1. Bovine

            10.3.2. Porcine

        10.4. North America Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

            10.4.1. Oral

            10.4.2. Parenteral

        10.5. North America Heparin Market Value (US$ Mn) Forecast, by Country, 2017–2027

            10.5.1. U.S.

            10.5.2. Canada

        10.6. North America Heparin Market Attractiveness Analysis

            10.6.1. By Product

            10.6.2. By Source

            10.6.3. By Formulation

            10.6.4. By Country

    11. Europe Heparin Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Europe Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

            11.2.1. Low Molecular Weight Heparin (LMWH)

            11.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

            11.2.3. Unfractionated Heparin (UFH)

        11.3. Europe Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

            11.3.1. Bovine

            11.3.2. Porcine

        11.4. Europe Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

            11.4.1. Oral

            11.4.2. Parenteral

        11.5. Europe Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Europe Heparin Market Attractiveness Analysis

            11.6.1. By Product

            11.6.2. By Source

            11.6.3. By Formulation

            11.6.4. By Country/Sub-region

    12. Asia Pacific Heparin Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

            12.2.1. Low Molecular Weight Heparin (LMWH)

            12.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

            12.2.3. Unfractionated Heparin (UFH)

        12.3. Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

            12.3.1. Bovine

            12.3.2. Porcine

        12.4. Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

            12.4.1. Oral

            12.4.2. Parenteral

        12.5. Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Asia Pacific Heparin Market Attractiveness Analysis

            12.6.1. By Product

            12.6.2. By Source

            12.6.3. By Formulation

            12.6.4. By Country/Sub-region

    13. Latin America Heparin Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Latin America Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

            13.2.1. Low Molecular Weight Heparin (LMWH)

            13.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

            13.2.3. Unfractionated Heparin (UFH)

        13.3. Latin America Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

            13.3.1. Bovine

            13.3.2. Porcine

        13.4. Latin America Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

            13.4.1. Oral

            13.4.2. Parenteral

        13.5. Latin America Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America Latin America

        13.6. Latin America Heparin Market Attractiveness Analysis

            13.6.1. By Product

            13.6.2. By Source

            13.6.3. By Formulation

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Heparin Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Product, 2017–2027

            14.2.1. Low Molecular Weight Heparin (LMWH)

            14.2.2. Ultra-low Molecular Weight Heparin (ULMWH)

            14.2.3. Unfractionated Heparin (UFH)

        14.3. Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Source, 2017–2027

            14.3.1. Bovine

            14.3.2. Porcine

        14.4. Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Formulation, 2017–2027

            14.4.1. Oral

            14.4.2. Parenteral

        14.5. Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Middle East & Africa Heparin Market Attractiveness Analysis

            14.6.1. By Product

            14.6.2. By Source

            14.6.3. By Formulation

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by Tier and Size of companies)

        15.2. Market Share / Position Analysis, by Company, 2018

        15.3. Competitive Business Strategies

        15.4. Company Profiles

            15.4.1. Dr. Reddy’s Laboratories Ltd

                15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.1.2. Growth Strategies

                15.4.1.3. SWOT Analysis

            15.4.2. Teva Pharmaceutical Industries Ltd

                15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.2.2. Growth Strategies

                15.4.2.3. SWOT Analysis

            15.4.3. Fresenius SE & Co. KGaA

                15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.3.2. Growth Strategies

                15.4.3.3. SWOT Analysis

            15.4.4. Sanofi

                15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.4.2. Growth Strategies

                15.4.4.3. SWOT Analysis

            15.4.5. Pfizer, Inc.

                15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.5.2. Growth Strategies

                15.4.5.3. SWOT Analysis

            15.4.6. LEO Pharma A/S

                15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.6.2. Growth Strategies

                15.4.6.3. SWOT Analysis

            15.4.7. Aspen

                15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.7.2. Growth Strategies

                15.4.7.3. SWOT Analysis

            15.4.8. Baxter International Inc.

                15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.8.2. Growth Strategies

                15.4.8.3. SWOT Analysis

            15.4.9. B. Braun Melsungen AG

                15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.9.2. Growth Strategies

                15.4.9.3. SWOT Analysis

            15.4.10. Syntex S.A

                15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.4.10.2. Growth Strategies

                15.4.10.3. SWOT Analysis

    List of Table

    Table 1: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 2: Global Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 3: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

    Table 4: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Region, 2018-2027

    Table 5: North America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 6: North America Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 7: North America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

    Table 8: North America Heparin Market Value (US$ Mn) Forecast, by Country, 2018-2027

    Table 9: U.S. Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 10: U.S. Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 11: Canada Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 12: Canada Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 13: Europe Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 14: Europe Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 15: Europe Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

    Table 16: Europe Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2027

    Table 17: Germany Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 18: Germany Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 19: U.K. Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 20: U.K. Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 21: France Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 22: France Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 23: Italy Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 24: Italy Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 25: Spain Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 26: Spain Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 27: Rest of Europe Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 28: Rest of Europe Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 29: Asia Pacific Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

    Table 30: Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 31: Asia Pacific Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

    Table 32: Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Country, 2018-2027

    Table 33: China Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

    Table 34: China Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 35: India Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

    Table 36: India Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 37: Japan Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

    Table 38: Japan Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 39: Australia Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

    Table 40: Australia Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 41: Indonesia Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

    Table 42: Indonesia Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 43: Malaysia Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

    Table 44: Malaysia Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 45: Rest of Asia Pacific Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product Type, 2018-2027

    Table 46: Rest of Asia Pacific Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 47: Middle East & Africa Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 48: Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 49: Middle East & Africa Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

    Table 50: Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2027

    Table 51: GCC Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 52: GCC Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 53: South Africa Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 54: South Africa Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 55: Morocco Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 56: Morocco Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 57: Israel Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 58: Israel Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 59: Tunisia Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 60: Tunisia Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 61: Egypt Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 62: Egypt Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 63: Turkey Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 64: Turkey Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 65: Rest of Middle East & Africa Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 66: Rest of Middle East & Africa Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 67: Latin America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 68: Latin America Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 69: Latin America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Formulation, 2018-2027

    Table 70: Latin America Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2027

    Table 71: Brazil Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 72: Brazil Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 73: Mexico Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 74: Mexico Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 75: Argentina Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 76: Argentina Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 77: Rest of Latin America Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Product, 2018-2027

    Table 78: Rest of Latin America Heparin Market Value (US$ Mn) Forecast, by Source, 2018-2027

    Table 79: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Muslim Countries, 2018-2027

    Table 80: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Non Muslim Countries, 2018-2027

    Table 81: Global Heparin Market Value (US$ Mn) and Volume (Million Megas) Forecast, by Non Muslim Countries, 2018-2027

    List of Figure

    Figure 01: Global Heparin Market Share, by Product (US$ Mn), 2018

    Figure 02: Global Heparin Market Share, by Source (% Share), 2018

    Figure 03: Market Opportunity Map

    Figure 04: Global Heparin Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2019–2027

    Figure 05: Market Value Share, by Product Type (2018)

    Figure 06: Market Value Share, by Formulation (2018)

    Figure 07: Market Value Share, by Source (2018)

    Figure 08: Market Value Share, by Region (2018)

    Figure 09: Global Heparin Market Value Share Analysis, by Product, 2018 and 2027

    Figure 10: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth, by Unfractionated Heparin (UFH), 2018–2027

    Figure 11: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth, by Low Molecular Weight Heparin (LMWH), 2018–2027

    Figure 12: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth, by Ultra-low Molecular Weight Heparin (ULMWH), 2018–2027

    Figure 13: Global Heparin Market Attractiveness Analysis, by Product

    Figure 14: Global Heparin Market Value Share Analysis, by Source, 2018 and 2027

    Figure 15: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bovine, 2018–2027

    Figure 16: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porcine, 2018–2027

    Figure 17: Global Heparin Market Attractiveness, by Source

    Figure 18: Global Heparin Market Value Share Analysis, by Formulation, 2018 and 2027

    Figure 19: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral Formulation, 2018–2027

    Figure 20: Global Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral Formulation, 2018–2027

    Figure 21: Global Heparin Market Attractiveness, by Formulation

    Figure 22: Global Heparin Market Value Share Analysis, by Region, 2018 and 2027

    Figure 23: Global Heparin Market Attractiveness Analysis, by Region

    Figure 24: North America Heparin Market Size (US$ Mn) Forecast, 2019–2027

    Figure 25: North America Heparin Market Attractiveness Analysis, by Country

    Figure 26: North America Heparin Market Value Share Analysis, by Product, 2018 and 2027

    Figure 27: North America Heparin Market Value Share Analysis, by Source, 2018 and 2027

    Figure 28: North America Heparin Market Value Share Analysis, by Formulation, 2018 and 2027

    Figure 29: North America Heparin Market Attractiveness Analysis, by Product

    Figure 30: North America Heparin Market Attractiveness Analysis, by Source

    Figure 31: North America Heparin Market Attractiveness Analysis, by Formulation

    Figure 32: North America Heparin Market Value Share Analysis, by Country, 2018 and 2027

    Figure 33: Europe Heparin Market Size (US$ Mn) Forecast, 2019–2027

    Figure 34: Europe Heparin Market Attractiveness Analysis, by Country/Sub-region

    Figure 35: Europe Heparin Market Value Share Analysis, by Product, 2018 and 2027

    Figure 36: Europe Heparin Market Value Share Analysis, by Source, 2018 and 2027

    Figure 37: Middle East & Africa Heparin Market Value Share Analysis, by Formulation, 2018 and 2027

    Figure 38: Middle East & Africa Heparin Market Attractiveness Analysis, by Product

    Figure 39: Middle East & Africa Heparin Market Attractiveness Analysis, by Source

    Figure 40: Middle East & Africa Heparin Market Attractiveness Analysis, by Formulation

    Figure 41: Middle East & Africa Heparin Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 42: Latin America Heparin Market Size (US$ Mn) Forecast, 2019–2027

    Figure 43: Latin America Heparin Market Attractiveness Analysis, by Country

    Figure 44: Latin America Heparin Market Value Share Analysis, by Product, 2018 and 2027

    Figure 45: Latin America Heparin Market Value Share Analysis, by Source, 2018 and 2027

    Figure 46: Latin America Heparin Market Value Share Analysis, by Formulation, 2018 and 2027

    Figure 47: Latin America Heparin Market Attractiveness Analysis, by Product

    Figure 48: Latin America Heparin Market Attractiveness Analysis, by Source

    Figure 49: Latin America Heparin Market Attractiveness Analysis, by Formulation

    Figure 50: Latin America Heparin Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 51: Global Heparin Market Forecast split, by Muslim Countries and Non Muslim Countries, 2018

    Figure 52: Global Heparin Market Share Analysis, by Company, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Heparin Market

Schedule a Call